N

NEXEL

18 employees

NEXEL is a biotechnology research firm that specializes in the advancement of drugs, biotherapeutics, and iPSC technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Human Cell Products
Drug Toxicity Screening
Fibrosis
Stem Cell
Medical
Drug Screening
Drug Development
Cell Products
Protein Therapy

Date founded

2012

Funding rounds raised

Total raised

$16M

from 4 investors over 4 rounds

N

NEXEL raised $16M on April 16, 2021

Investors: NH Investment & Securities, UTC Investment Co.,Ltd. and Ebest Investment Securities Co Ltd

N

NEXEL raised undisclosed on March 1, 2017

Investors: TIPS Town

FAQ